Biognosys provides next generation proteomics technology to quantify thousands of proteins for biomarker discovery or mode of action studies. The technology is available to researchers worldwide through our contract research services or our innovative reagent and software products. Biognosys was acquired by Burker in 2023.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2008
  • Number of employees in Switzerland
    20-49

You may also be interested in